Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients

Table 6 Risk factors selected from multivariate analysis without OKT3 and daclizumab

Covariates	Hazard ratio (95%CI)	P value
Age	1.068 (1.062-1.075)	< 0.001
Female	0.412 (0.344-0.494)	< 0.001
HLA mismatch level	0.948 (0.903-0.996)	0.034
Race
White	1	-
Black	0.126 (0.060-0.265)	< 0.001
Hispanic	0.058 (0.033-0.102)	< 0.001
Other	0.228 (0.154-0.339)	< 0.001
Diagnosis
Dilated myopathy	1	-
Restrictive myopathy	1.897 (1.354-2.658)	< 0.001
Heart re-transplant	1.703 (1.226-2.366)	0.002
Coronary artery disease	1.135 (0.927-1.389)	0.219
Hypertrophic myopathy	1.589 (1.082-2.334)	0.018
Valvular heart disease	1.156 (0.840-1.592)	0.373
Congenital heart defect	1.098 (0.645-1.872)	0.730
Other	1.329 (0.913-1.935)	0.138
Malignancy at listing
No	1	-
Yes	1.589 (1.312-1.925)	< 0.001
Unknown	0.983 (0.666-1.449)	0.930

HLA: Human leukocyte antigen; CI: Confidence interval.